Table 3.
Mean OMDS in Cycle 2–Week 4, 8, and 12 and mean degree of improvement in Cycle 2–Week 4, 8, and 12 from baseline (full analysis set)
Mogamulizumab n = 31 |
Placebo n = 31 |
p value | ||
---|---|---|---|---|
Mean OMDS | Mean ± SD | 4.51 ± 0.99 | 4.63 ± 0.95 | |
Mean degree of improvement in OMDS from baseline | Mean ± SD | 0.17 ± 0.37 | 0.24 ± 0.41 | |
Difference (95% CI) | − 0.06 (− 0.26 to 0.13) | 0.517 |
CI confidence interval, OMDS Osame motor disability score, SD standard deviation